TRVI
Trevi Therapeutics Inc.
$11.66
+$0.49(+4.39%)
60
Overall
45
Value
90
Tech
47
Quality
Market Cap
$1.28B
Volume
1.90M
52W Range
$2.36 - $11.68
Target Price
$20.36
EPS Estimates Overview
| Current Quarter | $-0.1 | Next Quarter | $-0.11 |
| Current Year | $-0.39 | Next Year | $-0.54 |
| QoQ Growth | -10.0% | YoY Growth | -38.5% |
| 3Y EPS CAGR | N/A | Target Price | $20.36 |
| Consensus | Buy | Upside | +74.6% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRVI | $11.66 | +4.4% | 1.90M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |